{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-23-000146","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.049434+00:00","generated_at":"2026-06-08T18:21:08.746733+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Axogen Q3 revenue $41.3M (+12% YoY); maintains FY2023 guidance $154-159M","bullets":["Revenue $41.3M (+12% YoY); scheduled non-trauma grew ~20%, emergent trauma mid-single digits.","Net loss $4.1M ($0.10/sh); adjusted net income $0.7M ($0.01/sh); Adj. EBITDA $2.4M vs $0.4M.","Gross margin 80.5% (down from 83.3%); FY2023 gross margin expected ~80%.","Cash & investments $38.6M; new processing facility began tissue processing in Aug.","Core Accounts 372 (+12% YoY); revenue from Core Accounts now ~65% of total."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-23-000146","json":"https://secwatch.observer/filing/0000805928-23-000146.json","markdown":"https://secwatch.observer/filing/0000805928-23-000146.md","text":"https://secwatch.observer/filing/0000805928-23-000146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000146/0000805928-23-000146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000146/axgn-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T18:21:08.746733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b573f9b9c96e35104b6967d938d657638efb2a1b","claim":"Axogen, Inc. reported full year 2023 results: revenue $154 million to $159 million. Guidance reaffirmed.","evidence_excerpt":"Management is maintaining full-year 2023 revenue guidance in the range of $154 million to $159 million, which represents annual growth of 11% - 15%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000146/0000805928-23-000146-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"$154 million to $159 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"ec000eb3755034f03b11dec06af92bfb30a78009","claim":"Axogen, Inc. reported third quarter ended September 30, 2023 results: net income Net loss of $4.1 million, EPS $0.10 per share.","evidence_excerpt":"Revenue was $41.3 million during the third quarter, an increase of approximately 12% over the third quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000146/0000805928-23-000146-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Net income","value":"Net loss of $4.1 million"},{"label":"EPS","value":"$0.10 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ec000eb3755034f03b11dec06af92bfb30a78009","claim":"Axogen, Inc. reported third quarter ended September 30, 2023 results: net income Net loss of $4.1 million, EPS $0.10 per share.","evidence_excerpt":"Net loss of $4.1 million, or $0.10 per share, compared to net loss of $4.3 million, or $0.10 per share in the third quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000146/0000805928-23-000146-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Net income","value":"Net loss of $4.1 million"},{"label":"EPS","value":"$0.10 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}